NMR screening methods for drug discovery

Matthew D. Shortridge, Robert Powers

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Drug discovery is a challenging endeavor with a high failure rate. This is further complicated by the fact that each disease has its own unique set of obstacles to developing a safe and effective therapy. Flexible and robust analytical methods are critical for efficiently solving these issues, where nuclear magnetic resonance (NMR) plays an important role in nearly every stage of the drug discovery process. This review will highlight recent developments in the application of NMR as a screening tool for drug discovery that includes: library design, various ligand-affinity screening techniques, rapid determination of protein-ligand co-structures, and the functional annotation of proteins to the discovery of new therapeutic targets.

Original languageEnglish (US)
Title of host publicationBiomolecular NMR Spectroscopy
EditorsAndrew Dingley, Steven Pascal
Pages381-412
Number of pages32
DOIs
StatePublished - Dec 1 2011

Publication series

NameAdvances in Biomedical Spectroscopy
Volume3
ISSN (Print)1875-0656

Fingerprint

Drug Discovery
Magnetic Resonance Spectroscopy
Ligands
Molecular Sequence Annotation
Libraries
Therapeutics
Proteins

Keywords

  • Drug discovery
  • NMR ligand-affinity screens
  • functional annotation
  • library design
  • rapid co-structures

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Shortridge, M. D., & Powers, R. (2011). NMR screening methods for drug discovery. In A. Dingley, & S. Pascal (Eds.), Biomolecular NMR Spectroscopy (pp. 381-412). (Advances in Biomedical Spectroscopy; Vol. 3). https://doi.org/10.3233/978-1-60750-695-9-381

NMR screening methods for drug discovery. / Shortridge, Matthew D.; Powers, Robert.

Biomolecular NMR Spectroscopy. ed. / Andrew Dingley; Steven Pascal. 2011. p. 381-412 (Advances in Biomedical Spectroscopy; Vol. 3).

Research output: Chapter in Book/Report/Conference proceedingChapter

Shortridge, MD & Powers, R 2011, NMR screening methods for drug discovery. in A Dingley & S Pascal (eds), Biomolecular NMR Spectroscopy. Advances in Biomedical Spectroscopy, vol. 3, pp. 381-412. https://doi.org/10.3233/978-1-60750-695-9-381
Shortridge MD, Powers R. NMR screening methods for drug discovery. In Dingley A, Pascal S, editors, Biomolecular NMR Spectroscopy. 2011. p. 381-412. (Advances in Biomedical Spectroscopy). https://doi.org/10.3233/978-1-60750-695-9-381
Shortridge, Matthew D. ; Powers, Robert. / NMR screening methods for drug discovery. Biomolecular NMR Spectroscopy. editor / Andrew Dingley ; Steven Pascal. 2011. pp. 381-412 (Advances in Biomedical Spectroscopy).
@inbook{403859618fcc46deab56e21419c7479c,
title = "NMR screening methods for drug discovery",
abstract = "Drug discovery is a challenging endeavor with a high failure rate. This is further complicated by the fact that each disease has its own unique set of obstacles to developing a safe and effective therapy. Flexible and robust analytical methods are critical for efficiently solving these issues, where nuclear magnetic resonance (NMR) plays an important role in nearly every stage of the drug discovery process. This review will highlight recent developments in the application of NMR as a screening tool for drug discovery that includes: library design, various ligand-affinity screening techniques, rapid determination of protein-ligand co-structures, and the functional annotation of proteins to the discovery of new therapeutic targets.",
keywords = "Drug discovery, NMR ligand-affinity screens, functional annotation, library design, rapid co-structures",
author = "Shortridge, {Matthew D.} and Robert Powers",
year = "2011",
month = "12",
day = "1",
doi = "10.3233/978-1-60750-695-9-381",
language = "English (US)",
isbn = "9781607506942",
series = "Advances in Biomedical Spectroscopy",
pages = "381--412",
editor = "Andrew Dingley and Steven Pascal",
booktitle = "Biomolecular NMR Spectroscopy",

}

TY - CHAP

T1 - NMR screening methods for drug discovery

AU - Shortridge, Matthew D.

AU - Powers, Robert

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Drug discovery is a challenging endeavor with a high failure rate. This is further complicated by the fact that each disease has its own unique set of obstacles to developing a safe and effective therapy. Flexible and robust analytical methods are critical for efficiently solving these issues, where nuclear magnetic resonance (NMR) plays an important role in nearly every stage of the drug discovery process. This review will highlight recent developments in the application of NMR as a screening tool for drug discovery that includes: library design, various ligand-affinity screening techniques, rapid determination of protein-ligand co-structures, and the functional annotation of proteins to the discovery of new therapeutic targets.

AB - Drug discovery is a challenging endeavor with a high failure rate. This is further complicated by the fact that each disease has its own unique set of obstacles to developing a safe and effective therapy. Flexible and robust analytical methods are critical for efficiently solving these issues, where nuclear magnetic resonance (NMR) plays an important role in nearly every stage of the drug discovery process. This review will highlight recent developments in the application of NMR as a screening tool for drug discovery that includes: library design, various ligand-affinity screening techniques, rapid determination of protein-ligand co-structures, and the functional annotation of proteins to the discovery of new therapeutic targets.

KW - Drug discovery

KW - NMR ligand-affinity screens

KW - functional annotation

KW - library design

KW - rapid co-structures

UR - http://www.scopus.com/inward/record.url?scp=84865470647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865470647&partnerID=8YFLogxK

U2 - 10.3233/978-1-60750-695-9-381

DO - 10.3233/978-1-60750-695-9-381

M3 - Chapter

SN - 9781607506942

T3 - Advances in Biomedical Spectroscopy

SP - 381

EP - 412

BT - Biomolecular NMR Spectroscopy

A2 - Dingley, Andrew

A2 - Pascal, Steven

ER -